These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34045218)

  • 1. Proteomic Quantification of Changes in Abundance of Drug-Metabolizing Enzymes and Drug Transporters in Human Liver Cirrhosis: Different Methods, Similar Outcomes.
    El-Khateeb E; Al-Majdoub ZM; Rostami-Hodjegan A; Barber J; Achour B
    Drug Metab Dispos; 2021 Aug; 49(8):610-618. PubMed ID: 34045218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic quantification of perturbation to pharmacokinetic target proteins in liver disease.
    Vasilogianni AM; El-Khateeb E; Al-Majdoub ZM; Alrubia S; Rostami-Hodjegan A; Barber J; Achour B
    J Proteomics; 2022 Jul; 263():104601. PubMed ID: 35537666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Label-Free but Still Constrained: Assessment of Global Proteomic Strategies for the Quantification of Hepatic Enzymes and Transporters.
    Barber J; Al-Majdoub ZM; Couto N; Vasilogianni AM; Tillmann A; Alrubia S; Rostami-Hodjegan A; Achour B
    Drug Metab Dispos; 2022 Jun; 50(6):762-769. PubMed ID: 35307650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Tissue Abundance of Membrane-Bound Drug Metabolizing Enzymes and Transporter Proteins by Global Proteomics.
    Singh DK; Ahire D; Davydov DR; Prasad B
    Drug Metab Dispos; 2024 Oct; 52(11):1152-1160. PubMed ID: 38641346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-uniformity of Changes in Drug-Metabolizing Enzymes and Transporters in Liver Cirrhosis: Implications for Drug Dosage Adjustment.
    El-Khateeb E; Achour B; Al-Majdoub ZM; Barber J; Rostami-Hodjegan A
    Mol Pharm; 2021 Sep; 18(9):3563-3577. PubMed ID: 34428046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global Proteomic Analysis of Human Liver Microsomes: Rapid Characterization and Quantification of Hepatic Drug-Metabolizing Enzymes.
    Achour B; Al Feteisi H; Lanucara F; Rostami-Hodjegan A; Barber J
    Drug Metab Dispos; 2017 Jun; 45(6):666-675. PubMed ID: 28373266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Proteomics Analysis of Human Liver Microsomes and S9 Fractions.
    Wang X; He B; Shi J; Li Q; Zhu HJ
    Drug Metab Dispos; 2020 Jan; 48(1):31-40. PubMed ID: 31699809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Label-free absolute protein quantification with data-independent acquisition.
    He B; Shi J; Wang X; Jiang H; Zhu HJ
    J Proteomics; 2019 May; 200():51-59. PubMed ID: 30880166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of Proteins Involved in Drug Metabolism and Disposition in the Human Liver Using Label-Free Global Proteomics.
    Couto N; Al-Majdoub ZM; Achour B; Wright PC; Rostami-Hodjegan A; Barber J
    Mol Pharm; 2019 Feb; 16(2):632-647. PubMed ID: 30608694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontogeny of Small Intestinal Drug Transporters and Metabolizing Enzymes Based on Targeted Quantitative Proteomics.
    Kiss M; Mbasu R; Nicolaï J; Barnouin K; Kotian A; Mooij MG; Kist N; Wijnen RMH; Ungell AL; Cutler P; Russel FGM; de Wildt SN
    Drug Metab Dispos; 2021 Dec; 49(12):1038-1046. PubMed ID: 34548392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted quantitative proteomic analysis of drug metabolizing enzymes and transporters by nano LC-MS/MS in the sandwich cultured human hepatocyte model.
    Khatri R; Fallon JK; Rementer RJB; Kulick NT; Lee CR; Smith PC
    J Pharmacol Toxicol Methods; 2019; 98():106590. PubMed ID: 31158457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abundance of Phase 1 and 2 Drug-Metabolizing Enzymes in Alcoholic and Hepatitis C Cirrhotic Livers: A Quantitative Targeted Proteomics Study.
    Prasad B; Bhatt DK; Johnson K; Chapa R; Chu X; Salphati L; Xiao G; Lee C; Hop CECA; Mathias A; Lai Y; Liao M; Humphreys WG; Kumer SC; Unadkat JD
    Drug Metab Dispos; 2018 Jul; 46(7):943-952. PubMed ID: 29695616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transporter Expression in Liver Tissue from Subjects with Alcoholic or Hepatitis C Cirrhosis Quantified by Targeted Quantitative Proteomics.
    Wang L; Collins C; Kelly EJ; Chu X; Ray AS; Salphati L; Xiao G; Lee C; Lai Y; Liao M; Mathias A; Evers R; Humphreys W; Hop CE; Kumer SC; Unadkat JD
    Drug Metab Dispos; 2016 Nov; 44(11):1752-1758. PubMed ID: 27543206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Proteomic Quantification Approaches for Hepatic Drug Transporters: Multiplexed Global Quantitation Correlates with Targeted Proteomic Quantitation.
    Vildhede A; Nguyen C; Erickson BK; Kunz RC; Jones R; Kimoto E; Bourbonais F; Rodrigues AD; Varma MVS
    Drug Metab Dispos; 2018 May; 46(5):692-696. PubMed ID: 29439128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Proteomics of Clinically Relevant Drug-Metabolizing Enzymes and Drug Transporters and Their Intercorrelations in the Human Small Intestine.
    Couto N; Al-Majdoub ZM; Gibson S; Davies PJ; Achour B; Harwood MD; Carlson G; Barber J; Rostami-Hodjegan A; Warhurst G
    Drug Metab Dispos; 2020 Apr; 48(4):245-254. PubMed ID: 31959703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics of colorectal cancer liver metastasis: A quantitative focus on drug elimination and pharmacodynamics effects.
    Vasilogianni AM; Al-Majdoub ZM; Achour B; Peters SA; Rostami-Hodjegan A; Barber J
    Br J Clin Pharmacol; 2022 Feb; 88(4):1811-1823. PubMed ID: 34599518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent advances in the quantification of drug metabolizing enzymes and transporters by proteomic approach].
    Yang B; Wang J; Cong YT; Hu LH; Gu JK
    Yao Xue Xue Bao; 2015 Jun; 50(6):668-74. PubMed ID: 26521435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational value of liquid chromatography coupled with tandem mass spectrometry-based quantitative proteomics for in vitro-in vivo extrapolation of drug metabolism and transport and considerations in selecting appropriate techniques.
    Al Feteisi H; Achour B; Rostami-Hodjegan A; Barber J
    Expert Opin Drug Metab Toxicol; 2015; 11(9):1357-69. PubMed ID: 26108733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Proteomics of Hepatic Drug-Metabolizing Enzymes and Transporters in Patients With Colorectal Cancer Metastasis.
    Vasilogianni AM; Al-Majdoub ZM; Achour B; Annie Peters S; Barber J; Rostami-Hodjegan A
    Clin Pharmacol Ther; 2022 Sep; 112(3):699-710. PubMed ID: 35510337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous quantification of the abundance of several cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomics.
    Achour B; Russell MR; Barber J; Rostami-Hodjegan A
    Drug Metab Dispos; 2014 Apr; 42(4):500-10. PubMed ID: 24408517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.